PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise for leukemia patients Who've run out of options
Disease control Recruiting nowThis study tests an experimental pill called HQP1351 in adults with chronic myeloid leukemia (CML) or a related blood cancer (Ph+ ALL) that has stopped responding to at least two standard treatments. The goal is to find the best dose and check how safe and effective the drug is. …
Matched conditions: PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated May 26, 2026 06:21 UTC
-
Promising new combo therapy aims to improve leukemia treatment and reduce hospital stays
Disease control Recruiting nowThis study is for adults newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It tests a treatment plan that combines targeted drugs, reduced-intensity chemotherapy, and CAR-T cell therapy to deepen remission and reduce side effects. The g…
Matched conditions: PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 05:51 UTC